Provider review
AM Rx review
Operates under an active FTC/DOJ lawsuit over billing practices, at our last check
Semaglutide runs from $151 a month on a quarterly plan, with insurance coordination for brand drugs. Its own page code names a "zealthy-menu-container" — AM Rx is operated by FitRX, LLC, which also runs Zealthy, and that parent's legal record is worth reading before you enroll.
Received an FDA warning letter in June 2026 — see the FDA’s warning-letter database.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
AM Rx is a telehealth platform operated by FitRX, LLC — confirmed via a "zealthy-menu-container" class in the site's own code, matching our earlier finding that FitRX, LLC also operates Zealthy and FitRx as sibling brands. It offers insurance coordination for brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) as low as $25/month, and compounded semaglutide from $151/month on a quarterly plan. Unconfirmed since our last check, its parent company faces an active FTC/DOJ lawsuit over deceptive billing and subscription practices, has received two FDA warning letters (September 2025, February 2026) for misbranding compounded GLP-1s, faces a Novo Nordisk false-advertising lawsuit, and holds a BBB rating of D- with more than 2,370 complaints. Anyone considering AM Rx should verify the current status of each of these directly before enrolling.
AM Rx is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You've verified the current status of the FTC/DOJ lawsuit and FDA warning letters and are still comfortable enrolling
- You want insurance coordination for brand-name GLP-1s specifically
- You want video visits with providers averaging 10+ years of experience
Look elsewhere if
- You want a provider without active regulatory or legal scrutiny to research first
- You want a parent company with a strong BBB rating, not a D-
- You'd rather avoid a storefront that shares infrastructure with sibling brands under the same scrutiny
What it actually costs
What they advertise
Compounded semaglutide "from $151/mo" (quarterly plan); brand-name GLP-1s with insurance coordination "as low as $25/mo," per getamrx.com.
What you actually pay, month to month
The $151/mo figure requires the quarterly plan; the $25/mo brand-name figure depends on individual insurance coverage and is not guaranteed.
Checked live on AM Rx's own site at https://getamrx.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what AM Rx bundles in, and what it does not.
Clinician consult
Video and async consultations are available, per the homepage.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Providers average 10+ years of experience, per the homepage.
Injection supplies
Not itemized.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Not named.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Not published as a list.
The honest cons
The part they would rather you skipped
At our last check, this provider's parent company faces an active FTC/DOJ lawsuit over billing practices, two FDA warning letters, a Novo Nordisk false-advertising suit, and a D- BBB rating with thousands of complaints — none independently re-verified beyond the shared-operator evidence found in the site's own code, but each a matter of public record worth checking directly.
- Parent company faces an active FTC/DOJ lawsuit over billing practices, unconfirmed since our last check
- Two FDA warning letters for misbranding compounded GLP-1s, at our last check
- Novo Nordisk false-advertising lawsuit, at our last check
- Parent company BBB rating of D- with 2,370+ complaints, at our last check
None of this is unique to AM Rx — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. AM Rx is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect AM Rx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on AM Rx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.